Chua TP, Danielewski J, Bodiyabadu K, Bradshaw CS, Machalek DA, Garland SM, Plummer EL, Vodstrcil LA, Murray GL. Antimicrob Agents Chemother. 2022 Apr 14:e0024322. doi: 10.1128/aac.00243-22. Online ahead of print.PMID: 35420491

★ Editor’s Pick

Murray GL, Bodiyabadu K, Vodstrcil LA, Machalek DA, Danielewski, J, Plummer, EL, Garland,SM, Whiley, DM, Sweeney, EL, Bradshaw CS. ParC variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure Journal of Antimicrobial Chemotherapy, Accepted April 2022.

Sweeney EL, Whiley DM, Murray GL, Bradshaw CS. Mycoplasma genitalium: enhanced management using expanded individualised treatment strategies, Sex Health. Invited Review Sex Health Accepted March, 2022

Tickner JA, Bradshaw CS, Murray GL, Whiley DM Sweeney EL. Novel probe-based melting curve assays for the characterisation of fluoroquinolone resistance in Mycoplasma genitalium. Antimicrobial Agents and Chemotherapy Accepted Feb, 2022

Vodstrcil LA, Plummer EL, Doyle M, Murray GL, Bodiyabadu K,  Jensen JS, Whiley DM, Sweeney EL, Williamson DA, Chow EPF, Fairley CK, Bradshaw CS. Combination therapy for Mycoplasma genitalium, and new insights into the utility of parC mutant detection to improve cure. Clin Infect Dis Jan 4 2022.

Sweeney EL, Bradshaw CS, Murray GL & Whiley DM Individualised treatment of Mycoplasma genitalium infection – it is time to incorporate quinolone resistance testing into clinical care. Lancet Infect Dis Accepted Sept 2021